- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04747886
Inhibitory Control Adult Weight Management
August 26, 2024 updated by: Sarah Salvy, Cedars-Sinai Medical Center
Supplementing Evidence-based Commercial Weight Management Program With Inhibitory Control Training: a Pilot Study
The purpose of this pilot study is to explore the benefits of supplementing the WW (formerly Weight Watchers) online program with a cognitive training game (PolyRules!) among adults with overweight or obesity.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This two-arm pilot study will be used to estimate the effect size in weight loss of supplementing the WW (formerly Weight Watchers) online program with gamified inhibitory control training (PolyRules!) among adults with overweight or obesity.
Participants ages 18 and older (n=30) will be randomly assigned to one of two study arms: (1) WW (formerly Weight Watchers) only or (2) WW + Gamified inhibitory control training (PolyRules!).
All participants will complete demographic, medical history questionnaires and cognitive assessment battery at baseline/enrollment and after completing the 3-month intervention protocol.
All interactions with PolyRules!
and WW will be passively recorded to monitor the frequency of interaction with WW and PolyRules!.
Study Type
Interventional
Enrollment (Actual)
34
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
West Hollywood, California, United States, 90069
- Pacific Design Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 18 years of age or older
- Read, write and speak English with acceptable visual acuity
- BMI between 25-40 kg/m^2
Exclusion Criteria:
- Currently enrolled in weight loss interventions or undergoing bariatric surgery
- Pregnant women
- Individuals with severe cognitive delays or visual/hearing impairment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: WW Only
Participants will receive 3-month access to the WW digital program.
|
WW is a structured behavioral weight management program that focuses on diet, physical activity and mindset skills.
The dietary approach is based on creating an energy deficit diet to produce weight loss while also being attentive to the quality of the calories.
Specifically, the WW program assigns SmartPoints values to foods based on calories, sugar, saturated fat and protein.
In addition, particular foods are assigned a points value of zero (0) to encourage a healthier eating pattern (e.g.
fruits, vegetables, non-fat yogurt, fish).
|
|
Experimental: WW + PolyRules!
Participants will receive 3-month access to the WW digital program and the PolyRules!
app.
|
In addition to WW, participants will be asked to engage in daily cognitive training using the PolyRules!
app for three months.
They will be instructed to start with 20-min of daily cognitive training and to progressively increase their training time to 30-min.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
BMI at Three Months
Time Frame: Baseline, 3 months
|
BMI will be calculated by aggregating participants' self-reported height in meters and weight in kilograms at baseline and at 3 months.
Throughout the study, participants will be asked to self-report their weight through the WW (formerly Weight Watchers) online app.
This data will be used to calculate change in BMI.
|
Baseline, 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To explore whether inhibitory control training confers any benefits in self-reported diet
Time Frame: Baseline, 3 months
|
Diet quality will be assessed using participant's self-reported food intake through the WW (formerly Weight Watchers) online app.
This data will be leveraged to assess changes in adherence to dietary guidelines for fruits and vegetables, servings of whole grains, red/processed meats, alcoholic beverages and food/beverages with added sugars.
|
Baseline, 3 months
|
|
To explore whether inhibitory control training confers any increases in self-reported physical activity.
Time Frame: Baseline, 3 months
|
Physical activity will be assessed using participant's self-reported physical activity levels through the WW (formerly Weight Watchers) online app.
This data will be leveraged to assess changes in engagement in energy balance behaviors by capturing information on the type, duration and intensity of activity.
|
Baseline, 3 months
|
|
Change in performance on the cancellation task.
Time Frame: Baseline, 3 months
|
Attention and inhibitory control will be assessed using participant's change in performance on the cancellation task.
Performance will be measured by summing up the total number of errors committed within a specific time frame, such that lower scores are more favorable.
|
Baseline, 3 months
|
|
Change in performance on the countermanding task.
Time Frame: Baseline, 3 months
|
Attention and inhibitory control will also be assessed using participant's change in performance on the countermanding task.
Performance will be measured by summing the number of accurate responses within a 15 second timeframe, such that higher scores are more favorable.
|
Baseline, 3 months
|
|
Change in performance on the N-back task.
Time Frame: Baseline, 3 months
|
Change in working memory will be assessed using participant's performance on the N-back task.
Performance will be measured by looking at the number of errors such that more errors is a worse outcome.
|
Baseline, 3 months
|
|
Change in performance on the letter-number task.
Time Frame: Baseline, 3 months
|
Change in working memory will also be assessed using participant's performance on the letter-number task.
Performance will be measured by looking at error rates, such that higher error rates are worse outcomes.
|
Baseline, 3 months
|
|
Change in visuo-spatial working memory based on performance on the Corsi task.
Time Frame: Baseline, 3 months
|
Change in visuo-spatial working memory will be assessed by participant's performance on the Corsi tasks.
Performance will be measured by assessing the number of correct sequences, such that a larger number of correct sequences is a more favorable outcomes.
|
Baseline, 3 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Visuo-spatial Working Memory Based on Performance on the Corsi Task.
Time Frame: Baseline, 3 months
|
Change in visuo-spatial working memory will be assessed by participant's performance on the Corsi tasks.
Performance will be measured by assessing the number of correct sequences, such that a larger number of correct sequences is a more favorable outcomes.
|
Baseline, 3 months
|
|
Change in Performance on the Letter-number Task.
Time Frame: Baseline, 3 months
|
Change in working memory will also be assessed using participant's performance on the letter-number task.
Performance will be measured by looking at error rates, such that higher error rates are worse outcomes.
|
Baseline, 3 months
|
|
Change in Performance on the N-back Task.
Time Frame: Baseline, 3 months
|
Change in working memory will be assessed using participant's performance on the N-back task.
Performance will be measured by looking at the number of errors such that more errors is a worse outcome.
|
Baseline, 3 months
|
|
Change in Performance on the Cancellation Task.
Time Frame: Baseline, 3 months
|
Attention and inhibitory control will be assessed using participant's change in performance on the cancellation task.
Performance will be measured by summing up the total number of errors committed within a specific time frame, such that lower scores are more favorable.
|
Baseline, 3 months
|
|
To Explore Whether Inhibitory Control Training Confers Any Increases in Self-reported Physical Activity.
Time Frame: Baseline, 3 months
|
Physical activity will be assessed using participant's self-reported physical activity levels through the WW (formerly Weight Watchers) online app.
This data will be leveraged to assess changes in engagement in energy balance behaviors by capturing information on the type, duration and intensity of activity.
|
Baseline, 3 months
|
|
Change in Performance on the Countermanding Task.
Time Frame: Baseline, 3 months
|
Attention and inhibitory control will also be assessed using participant's change in performance on the countermanding task.
Performance will be measured by summing the number of accurate responses within a 15 second timeframe, such that higher scores are more favorable.
|
Baseline, 3 months
|
|
To Explore Whether Inhibitory Control Training Confers Any Benefits in Self-reported Diet
Time Frame: Baseline, 3 months
|
Diet quality will be assessed using participant's self-reported food intake through the WW (formerly Weight Watchers) online app.
This data will be leveraged to assess changes in adherence to dietary guidelines for fruits and vegetables, servings of whole grains, red/processed meats, alcoholic beverages and food/beverages with added sugars.
|
Baseline, 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sarah-Jeanne Salvy, PhD, Cedars-Sinai Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 12, 2021
Primary Completion (Actual)
July 31, 2021
Study Completion (Actual)
June 4, 2022
Study Registration Dates
First Submitted
January 25, 2021
First Submitted That Met QC Criteria
February 5, 2021
First Posted (Actual)
February 10, 2021
Study Record Updates
Last Update Posted (Actual)
August 29, 2024
Last Update Submitted That Met QC Criteria
August 26, 2024
Last Verified
August 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00001164
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight and Obesity
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
National Taiwan University HospitalCompleted
-
PfizerNot yet recruitingObesity | Overnutrition | Nutrition Disorders | Overweight | Body Weight | Overweight or Obesity | Overweight and/or Obesity | Nutritional and Metabolic DiseasesUnited States
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasRecruitingPediatric Obesity | Pediatric Overweight | Overweight , ObesityUnited States
-
Universidade do Extremo Sul Catarinense - Unidade...RecruitingObesity | Overweight and Obesity | Obesity; Endocrine | Overweight, Obesity and Other HyperalimentationBrazil
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Administração Regional de Saúde do... and other collaboratorsCompletedOverweight and ObesityPortugal
Clinical Trials on WW Only
-
University of LeedsWW International Inc.Terminated
-
Georgia Southern UniversityIndiana University; WW International IncCompletedOverweight and ObesityUnited States
-
Michelle Cardel, PhD, MS, RDCompleted
-
University of PennsylvaniaWW International IncCompleted
-
Pennington Biomedical Research CenterWW International IncWithdrawnObesity | Diabetes Mellitus, Type 2United States
-
Pennington Biomedical Research CenterWW International IncCompletedObesity | Diabetes Mellitus | Type 2 DiabetesUnited States
-
Medical University of South CarolinaWW InternationalCompletedObesity | Weight LossUnited States
-
Pennington Biomedical Research CenterWW International Inc.CompletedOverweight and Obesity | Type2 DiabetesUnited States
-
University of Colorado, BoulderNational Institute on Drug Abuse (NIDA)RecruitingStress | Cannabis UseUnited States
-
Cedars-Sinai Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); The... and other collaboratorsRecruiting